Ikena Oncology, Inc(NASDAQ:IKNA) 
Ikena Oncology, Inc., a targeted oncology company, focuses on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced ass...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.13
H 1.18
L 1.09
C 1.13
V 144,816
10EMA 1.13
20EMA 1.13
60EMA 1.13
120EMA 1.13
250EMA 1.13